PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33071214-0 2021 Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin. Vincristine 130-141 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 27-30 29065744-1 2018 Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) is associated with worse survival after standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) chemoimmunotherapy compared to germinal center B-cell-like (GCB) subtype. Vincristine 157-168 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 0-21 30339824-1 2019 In the present study, the molecular docking mechanism based on pharmacodynamic interactions between the ligands AZD1208 and recognized chemotherapy agents (Vincristine and Daunorubicin) with human ATP-binding cassette (ABC) transporters (ABCB1) was investigated. Vincristine 156-167 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 197-217 30339824-1 2019 In the present study, the molecular docking mechanism based on pharmacodynamic interactions between the ligands AZD1208 and recognized chemotherapy agents (Vincristine and Daunorubicin) with human ATP-binding cassette (ABC) transporters (ABCB1) was investigated. Vincristine 156-167 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 219-222 29065744-1 2018 Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) is associated with worse survival after standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) chemoimmunotherapy compared to germinal center B-cell-like (GCB) subtype. Vincristine 157-168 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 23-26 28847710-2 2017 Specifically, the nongerminal center B cell-like (non-GCB) subtype, composed predominantly of the activated B cell-like (ABC) molecular subtype, has been shown to portend poor prognosis because of its more aggressive nature and resistance to standard cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone (CHOP)-like chemotherapy compared with the GCB subtype. Vincristine 290-297 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 98-119 28847710-2 2017 Specifically, the nongerminal center B cell-like (non-GCB) subtype, composed predominantly of the activated B cell-like (ABC) molecular subtype, has been shown to portend poor prognosis because of its more aggressive nature and resistance to standard cyclophosphamide, hydroxydaunorubicin, oncovin, prednisone (CHOP)-like chemotherapy compared with the GCB subtype. Vincristine 290-297 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 121-124 25202056-0 2014 Expression of ABCB6 is related to resistance to 5-FU, SN-38 and vincristine. Vincristine 64-75 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 14-19 25202056-5 2014 ABCB6 expression enhanced resistance to 5-fluorouracil (5-FU), SN-38 and vincristine (Vcr) but not to arsenite. Vincristine 73-84 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 0-5 25202056-5 2014 ABCB6 expression enhanced resistance to 5-fluorouracil (5-FU), SN-38 and vincristine (Vcr) but not to arsenite. Vincristine 86-89 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 0-5 23462296-4 2013 This study demonstrates alterations in ABC and SLC gene expression levels in methotrexate, cisplatin, doxorubicin, vincristine, topotecan and paclitaxel-resistant variant of W1 ovarian cancer cell line. Vincristine 115-126 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 39-42 27737889-2 2016 It is well documented that ABC-DLBCL cases have a significantly poorer survival response than GCB-DLBCLs in both the CHOP (cyclophosphamide, vincristine, doxorubicin, and prednisone) and the rituximab (R)-CHOP eras. Vincristine 141-152 ATP binding cassette subfamily B member 6 (Langereis blood group) Homo sapiens 27-30